Illumina and Labcorp expand collaboration to broaden access to precision oncology testing

Illumina and Labcorp expand collaboration to broaden access to precision oncology testing Accessibility StatementSkip Navigation SAN DIEGO, March 18, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology through innovative applications of next-generation sequencing (NGS) solutions across the healthcare ecosystem. Projects are expected to include pr ...